Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
Phase: PHASE3 | Sponsor: Federal University of São Paulo | Compound: Ketamine
- Status
- planned
- Institution
- Federal University of São Paulo
- Start date
- 2025-05-01
- End date
- 2028-04-01
- Registry ID
- NCT06957704
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.